Literature DB >> 15701496

Laparoscopic fenestration for the treatment of patients with severe adult polycystic liver disease.

Manousos M Konstadoulakis1, Ilias P Gomatos, Kostantinos Albanopoulos, Nikolaos Alexakis, Emmanuel Leandros.   

Abstract

BACKGROUND: The purpose of this study was to present our experience in laparoscopic fenestration for patients with severe symptomatic adult polycystic liver disease (APLD), analyze its feasibility, and evaluate its immediate and mid-term outcome.
METHODS: Between January 2000 and January 2002, 9 patients underwent laparoscopic fenestration for symptomatic APLD in our laparoendoscopic unit. All patients had both liver lobes affected with multiple cysts, whereas type II disease (present in 8 patients) was not a contraindication for the procedure. The results were retrospectively evaluated.
RESULTS: Conversion to laparotomy was required in 1 patient who was submitted to a second laparoscopic procedure (2 years postoperatively) after being admitted to our department with sepsis. Complete regression of symptoms was achieved in 7 of our patients (77.8%). One death occurred because of acute renal failure established 5 weeks after the patient was discharged. During a mean follow-up of 25.8 months, 2 patients presented with recurrence of their symptoms (22.2%). One of them was reoperated on; both of them remain symptom free 14 months postoperatively.
CONCLUSIONS: Laparoscopic fenestration appears to be a useful and effective approach for severe APLD. It is associated with short hospital stay and a significant symptom-free period. Despite the reported morbidity, aggressive and meticulous deroofing of as many cysts as possible can be successfully applied for carefully selected patients with type II disease.

Entities:  

Mesh:

Year:  2005        PMID: 15701496     DOI: 10.1016/j.amjsurg.2004.03.011

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

Review 1.  Isolated polycystic liver disease.

Authors:  Qi Qian
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

Review 2.  Rare cystic liver lesions: a diagnostic and managing challenge.

Authors:  Andreas Bakoyiannis; Spiros Delis; Charina Triantopoulou; Christos Dervenis
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

3.  Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%.

Authors:  Loes van Keimpema; Jelle P Ruurda; Miranda F Ernst; Hendrikus J A A van Geffen; Joost P H Drenth
Journal:  J Gastrointest Surg       Date:  2007-10-24       Impact factor: 3.452

4.  Laparoscopic treatment of biliary hepatic cysts: short- and medium-term results.

Authors:  Vincenzo Neri; Antonio Ambrosi; Alberto Fersini; Tiziano Pio Valentino
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 5.  A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease.

Authors:  Niek F Casteleijn; Folkert W Visser; Joost P H Drenth; Tom J G Gevers; Gerbrand J Groen; Marie C Hogan; Ron T Gansevoort
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

6.  Long-term outcome after laparoscopic fenestration of simple liver cysts.

Authors:  Francesco Ardito; Giuseppe Bianco; Maria Vellone; Gerardo Sarno; Giuseppina Ranucci; Ivo Giovannini; Felice Giuliante
Journal:  Surg Endosc       Date:  2013-08-13       Impact factor: 4.584

7.  Fenestration of liver cysts in polycystic liver disease to improve quality of life: a case report and literature review.

Authors:  Dong-Hwan Jung; Shin Hwang; Chul-Soo Ahn; Deok-Bog Moon; Gi-Won Song; Ki-Hun Kim; Tae-Yong Ha; Gil-Chun Park; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2015-02-28

8.  Clinical response after laparoscopic fenestration of symptomatic hepatic cysts: a systematic review and meta-analysis.

Authors:  Lucas H P Bernts; Sebastiaan G Echternach; Wietske Kievit; Camiel Rosman; Joost P H Drenth
Journal:  Surg Endosc       Date:  2018-10-17       Impact factor: 4.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.